Research

Texas D-CFAR Grants and Funding

Master
Heading

2025 Texas D-CFAR Pilot Awards

Content

The Texas DCFAR is now accepting applications for the 2025 Pilot Awards!

Eligible investigators from participating institutions are invited to apply for two funding opportunities offered by the Developmental Core. Please refer to the documents below for eligibility criteria and application instructions.

Content

We provide our members with support to do cutting-edge research through:

  • Introductions to collaborators from our home institutions and the wider network of HIV-leading investigators
  • Identifying opportunities for funding through NIH or other funding bodies
  • Providing strategies for competitive grant applications and feedback from senior investigators on grant drafts  
  • Assistance with organizing multi-investigator grant submissions
  • Offering pilot grant funding to jumpstart or supplement your research endeavors

Submitting a grant?

Our Texas D-CFAR leadership can do a “mock review” to help you prepare a competitive grant application. 

Content

For funding opportunities visit the following sites:

Notice of Extension of NOT-HL-20-761 "Notice of Special Interest (NOSI): Pulmonary Complications of Hematopoietic Stem Cell Transplantation in Childhood". Expires Jan. 1, 2025

Notice of Special Interest (NOSI): Administrative Supplements for Research on Women's Health in the IDeA States. Expires Oct. 18, 2024

Notice of Expiration of NOT-HL-19-677 "Notice of Special Interest SEARCH: Stimulating ExplorAtory Research on HIV/AIDS Contribution to Heart, Lung, Blood and Sleep Comorbidities (R01 - Clinical Trial Not Allowed)". Expires Jan. 1, 2025

Application Due Date Changes for RFA-HL-23-013, "Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)". Expires Jan. 1, 2025

Application Due Date Changes for RFA-HL-23-014, "Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33)". Expires Jan. 1, 2025

Notice of Application Due Date Changes for RFA-HL-23-011,"Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)". Expires Jan. 1, 2025

Co-Sponsored FOAs

NOT-DA-21-060: Notice of Special Interest (NOSI): Reducing Stigma Related to Drug Use in Human Service Settings

NOT-MH-22-095: Notice of Special Interest: NIMH Priorities on Aggression and Violence Against Others